Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Apr;37(4):440–443. doi: 10.1136/jcp.37.4.440

An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.

R Cevenini, M Donati, F Rumpianesi, A Moroni, P Paolucci
PMCID: PMC498747  PMID: 6323549

Abstract

A technique using indirect immunoperoxidase antibody was developed for the detection of specific serum IgA antibody to Epstein-Barr virus capsid antigen and early antigen. The IgA technique was compared with an immunofluorescence antibody method. Epstein-Barr virus IgA antibody against viral capsid antigen was detected in all nine patients with Epstein-Barr virus associated undifferentiated nasopharyngeal carcinoma, in 13 (72.2%) of 18 patients with infectious mononucleosis, in 21 (28.3%) of 74 patients with acute lymphoblastic leukaemia, and in six (20%) of 30 patients who had recently had kidney transplants. Epstein-Barr virus IgA antibody against viral capsid antigen was also detected in four (10%) of 40 healthy subjects, but it was not found in any of 20 cord blood samples. Epstein-Barr virus IgA antibody to early antigen was detected in six (66.6%) patients with nasopharyngeal carcinoma and in two (2.7%) patients with acute lymphoblastic leukaemia. The immunoperoxidase assay for Epstein-Barr virus specific IgA was simple, reliable, and rapid and correlated well (r = 0.94) with the immunofluorescence antibody technique.

Full text

PDF
440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carpi C., Donati M., Musiani M., Zerbini M., Cevenini R., Feletti C. Serum antibody profile against herpesviruses in renal transplant recipients. Boll Ist Sieroter Milan. 1982;61(3):245–247. [PubMed] [Google Scholar]
  2. Cevenini R., Donati M., Moroni A., Franchi L., Rumpianesi F. Rapid immunoperoxidase assay for detection of respiratory syncytial virus in nasopharyngeal secretions. J Clin Microbiol. 1983 Oct;18(4):947–949. doi: 10.1128/jcm.18.4.947-949.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cevenini R., Rumpianesi F., Donati M., Sarov I. A rapid immunoperoxidase assay for the detection of specific IgG antibodies to Chlamydia trachomatis. J Clin Pathol. 1983 Mar;36(3):353–356. doi: 10.1136/jcp.36.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Edwards J. M., McSwiggan D. A. Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J Clin Pathol. 1974 Aug;27(8):647–651. doi: 10.1136/jcp.27.8.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edwards J. M., Woodroof M. EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages. J Clin Pathol. 1979 Oct;32(10):1036–1040. doi: 10.1136/jcp.32.10.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976 Jan 15;17(1):1–7. doi: 10.1002/ijc.2910170102. [DOI] [PubMed] [Google Scholar]
  8. Henle W., Ho J. H., Henle G., Chau J. C., Kwan H. C. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer. 1977 Nov 15;20(5):663–672. doi: 10.1002/ijc.2910200504. [DOI] [PubMed] [Google Scholar]
  9. Ho H. C., Ng M. H., Kwan H. C., Chau J. C. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer. 1976 Dec;34(6):655–660. doi: 10.1038/bjc.1976.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma. Int J Cancer. 1971 Nov 15;8(3):475–486. doi: 10.1002/ijc.2910080316. [DOI] [PubMed] [Google Scholar]
  11. Kurstak E., de Thé G., van den Hurk J., Charpentier G., Kurstak C., Tijssen P., Morisset R. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins. J Med Virol. 1978;2(3):189–200. doi: 10.1002/jmv.1890020302. [DOI] [PubMed] [Google Scholar]
  12. Lennette E. T., Ward E., Henle G., Henle W. Detection of antibodies to Epstein-Barr virus capsid antigen by immune adherence hemagglutination. J Clin Microbiol. 1982 Jan;15(1):69–73. doi: 10.1128/jcm.15.1.69-73.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marker S. C., Ascher N. L., Kalis J. M., Simmons R. L., Najarian J. S., Balfour H. H., Jr Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery. 1979 Apr;85(4):433–440. [PubMed] [Google Scholar]
  14. Nikoskelainen J., Neel E. U., Stevens D. A. Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. J Clin Microbiol. 1979 Jul;10(1):75–79. doi: 10.1128/jcm.10.1.75-79.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schmitz H. Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen. J Clin Microbiol. 1982 Aug;16(2):361–366. doi: 10.1128/jcm.16.2.361-366.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES